Pulmonary disease from biological agents: anthrax, plague, Q fever, and tularemia.

Anthrax, plague, Q fever, and tularemia are all potential inhalational bioterrorism agents. The pulmonary manifestations of these agents can be readily confused with each other as well as other more common diseases such as influenza and atypical pneumonia. This article reviews the threat potential, microbiology, pathogenesis, clinical features, diagnosis, and treatment of each of these agents and highlights the similarities and differences between their pulmonary presentations.

[1]  D H Walker,et al.  Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Philip K. Russell,et al.  Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. , 2000, JAMA.

[3]  C. R. Horsburgh,et al.  Pathology of emerging infections , 1997 .

[4]  P. Yarnold,et al.  Clinical predictors of bioterrorism-related inhalational anthrax , 2004, The Lancet.

[5]  K. Feldman,et al.  An outbreak of primary pneumonic tularemia on Martha's Vineyard. , 2001, The New England journal of medicine.

[6]  S. Chanteau,et al.  Epidemiological and diagnostic aspects of the outbreak of pneumonic plague in Madagascar , 2000, The Lancet.

[7]  David M. Bell,et al.  Clinical Issues in the Prophylaxis, Diagnosis, and Treatment of Anthrax , 2002, Emerging infectious diseases.

[8]  S. Chanteau,et al.  Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. , 1997, The New England journal of medicine.

[9]  Philip K. Russell,et al.  Tularemia as a biological weapon: medical and public health management. , 2001, JAMA.

[10]  S. Chanteau,et al.  Development and testing of a rapid diagnostic test for bubonic and pneumonic plague , 2003, The Lancet.

[11]  Michael K Jacobs.  The history of biologic warfare and bioterrorism. , 2004, Dermatologic clinics.

[12]  E. H. Derrick,et al.  “Q” FEVER, A NEW FEVER ENTITY: CLINICAL FEATURES, DIAGNOSIS AND LABORATORY INVESTIGATION , 1937 .

[13]  B. Cunha.  Anthrax, tularemia, plague, ebola or smallpox as agents of bioterrorism: recognition in the emergency room. , 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[14]  K. Morgan,et al.  Q fever--a forgotten disease? , 2002, The Lancet. Infectious diseases.

[15]  R. Weinstein,et al.  Q fever: a biological weapon in your backyard. , 2003, The Lancet. Infectious diseases.

[16]  A. Gikas,et al.  Q fever pneumonia: appearance on chest radiographs. , 1999, Radiology.

[17]  D. Raoult,et al.  Q Fever 1985‐1998: Clinical and Epidemiologic Features of 1,383 Infections , 2000, Medicine.

[18]  Y. Tselentis,et al.  Q fever pneumonia: CT findings. , 2000, Radiology.

[19]  2001: a year of major advances in anthrax toxin research. , 2002, Trends in microbiology.

[20]  E. Choi.  Tularemia and Q fever. , 2002, The Medical clinics of North America.

[21]  Safety precautions to limit exposure from plague-infected patients , 2000, JAMA.

[22]  S. Rubin.  Radiographic spectrum of pleuropulmonary tularemia. , 1978, AJR. American journal of roentgenology.

[23]  Jerome Hauer,et al.  Anthrax as a biological weapon, 2002: updated recommendations for management. , 2002, JAMA.

[24]  D. Pauze,et al.  Clinical presentation of inhalational anthrax following bioterrorism exposure: report of 2 surviving patients. , 2001, JAMA.

[25]  C. P. Quinn,et al.  Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. , 2001, Emerging infectious diseases.

[26]  A. Bryskier,et al.  Bacillus anthracis and antibacterial agents. , 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[27]  L. Rotz,et al.  Advances in detecting and responding to threats from bioterrorism and emerging infectious disease , 2004, Nature Medicine.

[28]  C. Fraser,et al.  Complete genome sequence of the Q-fever pathogen Coxiella burnetii , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[29]  D. Dennis,et al.  A major new test for plague , 2003, The Lancet.

[30]  R. Perry,et al.  Yersinia pestis--etiologic agent of plague , 1997, Clinical microbiology reviews.

[31]  Scott R. Lillibridge,et al.  Public Health Assessment of Potential Biological Terrorism Agents , 2002, Emerging infectious diseases.

[32]  S. Cronquist.  Tularemia: the disease and the weapon. , 2004, Dermatologic clinics.

[33]  Dori B. Reissman,et al.  Clinical features that discriminate inhalational anthrax from other acute respiratory illnesses. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  T. Fukao.  Immune system paralysis by anthrax lethal toxin: the roles of innate and adaptive immunity. , 2004, The Lancet. Infectious diseases.

[35]  T. Marrie.  Coxiella burnetii pneumonia , 2003, European Respiratory Journal.

[36]  E. J. Mark,et al.  Case 14-2000 , 2000 .

[37]  E. Croddy,et al.  Tularemia, biological warfare, and the battle for Stalingrad (1942-1943). , 2001, Military medicine.

[38]  Philip K. Russell,et al.  Botulinum toxin as a biological weapon: medical and public health management. , 2001, JAMA.

[39]  A. Sjöstedt,et al.  Tularaemia: bioterrorism defence renews interest in Francisella tularensis , 2004, Nature Reviews Microbiology.

[40]  R. Mayon-White,et al.  An outbreak of Q fever affecting postal workers in Oxfordshire. , 1987, The Journal of infection.